samedan logo
 
 
spacer
home > pmps > winter 2008 > packaging properties
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Packaging Properties

Declan Bogan, along with Gary Leonard and Mike Bigwood at Steripack, explores the principal materials used in the manufacture of healthcare packaging

The fundamental basis of packaging throughout the lifetime of a product is that it provides the following basic functionalities: protection, containment, presentation, identification, information, convenience, patient compliance and disposability. The packaging of any product is dictated by a number of factors, and the final packaging solution results from a series of trade-offs based on risk assessment, material suitability and application needs (see Table 1).

Flexible substrates, which most commonly include foils, films and papers, play a major part in the packaging decision process with flexible laminates frequently chosen as primary packaging.

FLEXIBLE PACKAGING MATERIALS AND PROPERTIES

Converting companies utilise manmade flexible packaging to produce rollstock, header bags, pouches, sachets, blisters and trays. There is no one super-substrate material that has all the desired properties for all applications. Creating an optimum flexible packaging solution for an application is achieved either by customising individual (mono) materials with heat-sealable coatings, or by combining several substrates (multi-layer) with their desirable properties into one structure all at a suitable cost (see Table 2).

MONO MATERIALS

Within the healthcare sector simple, mono materials are restricted in their application by their functionality, but are not uncommon. The following are some of the common materials utilised.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Declan Bogan has been working in the life sciences industry since completing his PhD at DCU in 1996. He has worked in a variety of roles both in Ireland and internationally for a variety of life sciences companies, both directly and as a consultant in the sector.
spacer
Dr Declan Bogan
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Bio-Rad Launches EconoFit Chromatography Column Packs

HERCULES, California, June 28, 2022: Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced the launch of EconoFit Low-Pressure Prepacked Chromatography Column Packs to support resin screening experiments in the development of protein purification workflows.
More info >>

White Papers

Analysis of Biopharmaceuticals to Conform to ICHQ6B

RSSL

Worldwide, the pharmaceuticals market is anticipated to grow from more than USD 782 billion in 2011 to approach a value of just over USD 971 billion by the end of 2016, registering a CAGR of over 24%. In 2010 the average medicines expenditure per person within the UK was 271, and this is expected to increase with the ageing population. A significant and increasing proportion of these sales are protein-based biotherapeutics or biomolecules. Currently, these account for 19% of the total market, and are growing at twice the rate of traditional small molecule pharmaceuticals. It is predicted that close to 50% of the top 100 pharmaceutical products will be biomolecules by 2016. By far the largest segment of the biopharmaceutical market is the monoclonal antibody (MAb) with an estimated share of 25.6%, which corresponds to USD 51.1 billion.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement